Product Information

DEXTROMETHORPHAN ER 30 MG/5 ML is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0674 per ML under NDC 45802043321. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on May 25, 2012.

DEXTROMETHORPHAN ER 30 MG/5 ML

dextromethorphan polistirex
$0.0674per ML
OTC

Strength

30 mg/5mL

NDC

45802043321

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091135

FDA Approved

5/25/2012

On Market Since

9/10/2012

Pharmacological Classes

Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists

Price Statistics

The NADAC for DEXTROMETHORPHAN ER 30 MG/5 ML has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 20.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0674 per ML
All-time high$0.0708 (Jun 14, 2023)
All-time low$0.0545 (Aug 23, 2017)
52-week high$0.0682
52-week low$0.0649
Median price$0.0574
Average price$0.0596
Largest weekly change-12.2% (Jun 21, 2023)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.5%

1M

-0.5%

3M

-1.0%

6M

-0.1%

1Y

+3.6%

3Y

+7.7%

5Y

+18.3%

All

+20.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROMETHORPHAN ER 30 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROMETHORPHAN ER 30 MG/5 ML, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0674 per ML (NDC 45802043321), effective Aug 19, 2026.

How has the price of DEXTROMETHORPHAN ER 30 MG/5 ML changed over time?

Over the history we have for it, the NADAC for DEXTROMETHORPHAN ER 30 MG/5 ML has risen 20.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DEXTROMETHORPHAN ER 30 MG/5 ML?

Since Nov 28, 2013, the NADAC for DEXTROMETHORPHAN ER 30 MG/5 ML has ranged from a low of $0.0545 (Aug 23, 2017) to a high of $0.0708 (Jun 14, 2023), with a median of $0.0574 per ML.

Are there cheaper alternatives to DEXTROMETHORPHAN ER 30 MG/5 ML?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, COUGH DM ER 30 MG/5 ML SUSP, is $0.0525 per ML — about 22% below DEXTROMETHORPHAN ER 30 MG/5 ML.

Who manufactures DEXTROMETHORPHAN ER 30 MG/5 ML?

DEXTROMETHORPHAN ER 30 MG/5 ML (NDC 45802043321) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.